Strides Pharma Science reports consolidated net profit of Rs 142.72 crore in the September 2019 quarter
Sales rise 37.62% to Rs 715.09 crore
Net profit of Strides Pharma Science reported to Rs 142.72 crore in the quarter ended September 2019 as against net loss of Rs 12.01 crore during the previous quarter ended September 2018. Sales rose 37.62% to Rs 715.09 crore in the quarter ended September 2019 as against Rs 519.61 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales715.09519.61 38 OPM %17.685.59 -PBDT107.8521.61 399 PBT65.85-9.25 LP NP142.72-12.01 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 25 2019 | 3:07 PM IST